• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝损伤B级患者肝细胞癌的微创肝切除术:基于倾向评分的分析

Minimally invasive liver resection for hepatocellular carcinoma of patients with liver damage B: A propensity score-based analysis.

作者信息

Noda Takehiro, Eguchi Hidetoshi, Iwagami Yoshifumi, Yamada Daisaku, Asaoka Tadafumi, Gotoh Kunihito, Kawamoto Koichi, Kobayashi Shogo, Hashimoto Yasuji, Takeda Yutaka, Tanemura Masahiro, Umeshita Koji, Doki Yuichiro, Mori Masaki

机构信息

Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.

Department of Surgery, Yao Municipal Hospital, Osaka, Japan.

出版信息

Hepatol Res. 2018 Jun;48(7):539-548. doi: 10.1111/hepr.13057. Epub 2018 Mar 7.

DOI:10.1111/hepr.13057
PMID:29316082
Abstract

AIM

Minimally invasive liver resection (MILR) is considered a safe and feasible treatment for malignant liver tumors. However, few studies have investigated the surgical outcomes of MILR in patients with impaired liver function. Liver damage is used for consideration of hepatectomy. The aim of this study is to clarify the efficacy of MILR for patients with impaired liver function by using propensity score matching.

METHODS

Ninety-nine patients with liver damage B underwent hepatic resection were analyzed. The patients were divided into two groups, the MILR group (n = 24) and the open liver resection (OLR) group (n = 75). After matching of a propensity score, we compared clinicopathological features and surgical outcomes.

RESULTS

After matching, 36 patients (18 patients from each group) were selected and the patients' characteristics and tumor characteristics were not significantly different between the two groups. Blood loss (P = 0.0163) and complication rate (P = 0.0162) were significantly decreased in the MILR group. Complications were observed in eight patients, comprising one patient in the MILR group and seven patients in the OLR group. The postoperative hospital stay was significantly shortened in the MILR group (P = 0.0118).

CONCLUSION

Minimally invasive liver resection might be effective for patients with impaired liver function. It reduces surgical complications and consequently shortens hospitalization time.

摘要

目的

微创肝切除术(MILR)被认为是治疗恶性肝肿瘤的一种安全可行的方法。然而,很少有研究调查肝功能受损患者接受MILR的手术效果。肝损伤是肝切除术考虑的因素。本研究的目的是通过倾向评分匹配来阐明MILR对肝功能受损患者的疗效。

方法

分析99例接受肝切除术的B级肝损伤患者。患者分为两组,MILR组(n = 24)和开放性肝切除术(OLR)组(n = 75)。在进行倾向评分匹配后,我们比较了临床病理特征和手术效果。

结果

匹配后,选择了36例患者(每组18例),两组患者的特征和肿瘤特征无显著差异。MILR组术中出血量(P = 0.0163)和并发症发生率(P = 0.0162)显著降低。观察到8例患者出现并发症,其中MILR组1例,OLR组7例。MILR组术后住院时间显著缩短(P = 0.0118)。

结论

微创肝切除术可能对肝功能受损患者有效。它可减少手术并发症,从而缩短住院时间。

相似文献

1
Minimally invasive liver resection for hepatocellular carcinoma of patients with liver damage B: A propensity score-based analysis.肝损伤B级患者肝细胞癌的微创肝切除术:基于倾向评分的分析
Hepatol Res. 2018 Jun;48(7):539-548. doi: 10.1111/hepr.13057. Epub 2018 Mar 7.
2
Minimally invasive versus open liver resection for hepatocellular carcinoma: a propensity score matching analysis of 224 patients.肝细胞癌的微创与开放肝切除术:224例患者的倾向评分匹配分析
Langenbecks Arch Surg. 2023 Mar 14;408(1):118. doi: 10.1007/s00423-023-02857-w.
3
Early Morbidity and Mortality after Minimally Invasive Liver Resection for Hepatocellular Carcinoma: a Propensity-Score Matched Comparison with Open Resection.微创肝切除术治疗肝细胞癌的早期发病率和死亡率:与开放性切除术的倾向评分匹配比较。
J Gastrointest Surg. 2019 Jul;23(7):1435-1442. doi: 10.1007/s11605-018-4016-2. Epub 2018 Oct 30.
4
Minimally invasive versus open right anterior sectionectomy and central hepatectomy for central liver malignancies: a propensity-score-matched analysis.微创与开放右前叶切除术及中央肝切除术治疗中央型肝脏恶性肿瘤:一项倾向评分匹配分析
ANZ J Surg. 2021 Apr;91(4):E174-E182. doi: 10.1111/ans.16719. Epub 2021 Mar 15.
5
Comparison between short and long-term outcomes after minimally invasive versus open primary liver resections for hepatocellular carcinoma: A 1:1 matched analysis.微创与开腹原发性肝癌肝切除术近期与远期疗效比较:1:1 匹配分析。
J Surg Oncol. 2021 Sep;124(4):560-571. doi: 10.1002/jso.26556. Epub 2021 Jun 1.
6
Minimally Invasive versus Open Liver Resection for Stage I/II Hepatocellular Carcinoma.I/II期肝细胞癌的微创与开放肝切除术
Cancers (Basel). 2021 Sep 25;13(19):4800. doi: 10.3390/cancers13194800.
7
Comparison of clinical and economic outcomes between minimally invasive liver resection and open liver resection: a propensity-score matched analysis.微创肝切除术与开腹肝切除术的临床和经济结局比较:倾向评分匹配分析。
HPB (Oxford). 2021 May;23(5):785-794. doi: 10.1016/j.hpb.2020.09.017. Epub 2020 Oct 10.
8
Surgical outcomes after laparoscopic or robotic liver resection in hepatocellular carcinoma: a propensity-score matched analysis with conventional open liver resection.肝细胞癌腹腔镜或机器人肝切除术后的手术结果:与传统开放性肝切除的倾向评分匹配分析
Int J Med Robot. 2016 Dec;12(4):735-742. doi: 10.1002/rcs.1714. Epub 2015 Nov 4.
9
Impact of liver cirrhosis on the difficulty of minimally-invasive liver resections: a 1:1 coarsened exact-matched controlled study.肝硬化对微创肝切除术难度的影响:1:1 粗糙精确匹配对照研究。
Surg Endosc. 2021 Sep;35(9):5231-5238. doi: 10.1007/s00464-020-08018-0. Epub 2020 Sep 24.
10
Minimally Invasive Liver Resection for Early-Stage Hepatocellular Carcinoma: Inconsistent Outcomes from Matched or Weighted Cohorts.微创肝切除术治疗早期肝细胞癌:匹配或加权队列的结果不一致。
J Gastrointest Surg. 2020 Mar;24(3):560-568. doi: 10.1007/s11605-019-04221-0. Epub 2019 Apr 22.

引用本文的文献

1
Survival analysis between laparoscopic and open hepatectomy for hepatocellular carcinoma: a meta-analysis based on reconstructed time-to-event data.基于重建时间事件数据的腹腔镜与开腹肝切除术治疗肝细胞癌的生存分析:荟萃分析。
Hepatol Int. 2021 Oct;15(5):1215-1235. doi: 10.1007/s12072-021-10219-1. Epub 2021 Jul 13.
2
Some Special Aspects of Liver Repair after Resection and Administration of Multipotent Stromal Cells in Experiment.实验中肝脏切除术后修复及多能基质细胞给药的一些特殊方面
Life (Basel). 2021 Jan 18;11(1):66. doi: 10.3390/life11010066.
3
Serum exosomal miR-638 is a prognostic marker of HCC via downregulation of VE-cadherin and ZO-1 of endothelial cells.
血清外泌体 miR-638 通过下调内皮细胞的 VE-钙黏蛋白和 ZO-1 成为 HCC 的预后标志物。
Cancer Sci. 2021 Mar;112(3):1275-1288. doi: 10.1111/cas.14807. Epub 2021 Jan 29.
4
Improved survival following splenectomy combined with curative treatments for hepatocellular carcinoma in Child B patients: A propensity score matching study.脾切除术联合Child B级肝细胞癌根治性治疗后生存率的提高:一项倾向评分匹配研究。
Hepatol Res. 2019 Feb;49(2):177-188. doi: 10.1111/hepr.13276. Epub 2019 Jan 4.